Concepedia

Neil D. Gross

ND

125

Publications

7.8K

Citations

49

H-Index

1987

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Oregon Health & Science University

Memorial Sloan Kettering Cancer Center

University of Pittsburgh

Johns Hopkins University

Neil D. Gross is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1987–2025

125

Publications

125

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi et al. · Nature Medicine · 2018 · 797 citations · Full text

, , +5

Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019

Anastasios Maniakas, Ramona Dadu, Naifa L. Busaidy et al. · JAMA Oncology · 2020 · 365 citations · Full text

, , +18

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Neil D. Gross, David M. Miller, Nikhil I. Khushalani et al. · New England Journal of Medicine · 2022 · 288 citations · Full text

Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

Priyanka Iyer, Ramona Dadu, Maria Gule-Monroe et al. · Journal for ImmunoTherapy of Cancer · 2018 · 232 citations · Full text

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid Carcinoma

Jennifer Wang, Mark Zafereo, Ramona Dadu et al. · Thyroid · 2019 · 224 citations · Full text

Rows per page

1–5 of 125